DRETINE אירלנד - אנגלית - HPRA (Health Products Regulatory Authority)

dretine

teva pharma b.v. - drospirenone ; ethinylestradiol - film coated tablet - 0.03 / 3 milligram - drospirenone and ethinylestradiol

DRETINELLE אירלנד - אנגלית - HPRA (Health Products Regulatory Authority)

dretinelle

teva pharma b.v. - drospirenone ; ethinylestradiol - film coated tablet - 0.02 / 3 milligram - drospirenone and estrogen

YAZ ישראל - אנגלית - Ministry of Health

yaz

bayer israel ltd - drospirenone; ethinylestradiol - film coated tablets - drospirenone 3 mg; ethinylestradiol 0.02 mg - drospirenone and estrogen - - oral contraception. - treatment of moderate acne vulgaris in women who seek oral contraception. - treatment of symptoms of premenstrual dysphoric disorder (pmdd ) in women who have chosen oral contraceptives as their method of birth control. the efficacy of yaz for pmdd was not assessed beyond 3 cycles. yaz has not been evaluated for treatment of pms ( premenstrual syndrome ).

Yasmin film-coated Tablets 0.03mg/3mg מלטה - אנגלית - Medicines Authority

yasmin film-coated tablets 0.03mg/3mg

bayer plc - drospirenone; ethinylestradiol - film-coated tablet - drospirenone 3 mg; ethinylestradiol 0.03 mg - sex hormones and modulators of the genital system

LIZ ישראל - אנגלית - Ministry of Health

liz

easy care ltd, israel - drospirenone; ethinylestradiol - film coated tablets - ethinylestradiol 0.02 mg; drospirenone 3 mg - drospirenone and estrogen - - oral contraception.- treatment of moderate acne vulgaris in women who seek oral contraception.- treatment of symptoms of premenstrual dysphoric disorder (pmdd ) in women who have chosen oral contraceptives as their method of birth control. the efficacy of ethinylestradiol and drospirenone combination for pmdd was not assessed beyond 3 cycles. ethinylestradiol and drospirenone combination has not been evaluated for treatment of pms ( premenstrual syndrome ).

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 28 קנדה - אנגלית - Health Canada

drospirenone and ethinyl estradiol tablets usp 28

glenmark pharmaceuticals canada inc. - drospirenone; ethinyl estradiol - tablet - 3mg; 0.03mg - drospirenone 3mg; ethinyl estradiol 0.03mg - contraceptives

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS 21 קנדה - אנגלית - Health Canada

drospirenone and ethinyl estradiol tablets 21

mylan pharmaceuticals ulc - drospirenone; ethinyl estradiol - tablet - 3mg; 0.03mg - drospirenone 3mg; ethinyl estradiol 0.03mg - progestogens and estrogens, fixed combinations

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS 28 קנדה - אנגלית - Health Canada

drospirenone and ethinyl estradiol tablets 28

mylan pharmaceuticals ulc - drospirenone; ethinyl estradiol - tablet - 3mg; 0.03mg - drospirenone 3mg; ethinyl estradiol 0.03mg - contraceptives

Isha 0.02mg/3mg film-coated tablets מלטה - אנגלית - Medicines Authority

isha 0.02mg/3mg film-coated tablets

mithra pharmaceuticals s.a rue saint-georges 5, 4000, liege, belgium - ethinylestradiol, drospirenone - film-coated tablet - ethinylestradiol 0.02 mg drospirenone 3 mg - sex hormones and modulators of the genital system

BROOKE drospirenone/ethinyloestradiol 3 mg/20 microgram tablet blister composite pack אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

brooke drospirenone/ethinyloestradiol 3 mg/20 microgram tablet blister composite pack

alphapharm pty ltd - ethinylestradiol, quantity: 0.02 mg; drospirenone, quantity: 3 mg - tablet - excipient ingredients: polacrilin potassium; magnesium stearate; lactose monohydrate - drospirenone/ethinyloestradiol-alphapharm 3/20 is indicated for use as: ? an oral contraceptive. ? treatment of moderate acne vulgaris in women who seek oral contraception ? treatment of symptoms of premenstrual dysphoric disorder (pmdd) in women who have chosen oral contraceptives as their method of birth control. the efficacy of drospirenone 3 mg/ethinyloestradiol 20 ?g tablets for pmdd was not assessed beyond 3 cycles. drospirenone 3 mg/ethinyloestradiol 20 ?g tablets has not been evaluated for treatment of pms (premenstrual syndrome) (see clinical trials).